5-Bromo-2-isopropylpyrimidine-4-carboxylic acid

Catalog No.: 
ACOBVO321
CAS No.: 
1267301-54-1
Molecular Formula: 
C8H9BrN2O2
Molecular Weight: 
245.08
5-Bromo-2-isopropylpyrimidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$119.00InquiryInquiry
100mg95%$169.00InquiryInquiry
250mg95%$234.00InquiryInquiry
1g95%$455.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-isopropylpyrimidine-4-carboxylic acid
IUPAC Name5-bromo-2-isopropylpyrimidine-4-carboxylic acid
MDL No.MFCD11870590
Molecular FormulaC8H9BrN2O2
Molecular Weight245.08
SMILESO=C(O)C1C(Br)=CN=C(C(C)C)N=1
InChI KeyZRKAYXAEJJRSBK-UHFFFAOYSA-N
Synonym5-bromo-2-(propan-2-yl)pyrimidine-4-carboxylic acid;4-Pyrimidinecarboxylic acid, 5-bromo-2-(1-methylethyl)-
CAS No.1267301-54-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOBVO321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIGMC543 route compound structure diagram
    ACIGMC54322007-68-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOBVO321 route product structure diagram
    ACOBVO3211267301-54-1
Inquiry

2. ACOBVO321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNQFY897 route compound structure diagram
    ACNQFY8971316122-22-1In Stock
  2. Then
  3. ACOBVO321 route product structure diagram
    ACOBVO3211267301-54-1
Inquiry

3. ACOBVO321 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOBVO321 route product structure diagram
    ACOBVO3211267301-54-1
Inquiry

Comments (0)